110 researchers already registered by these awesome organisations:
Bringing industry and researchers together!
In November 2016 BioMelbourne Network developed a new approach to industry and academic/research engagement with the workshop – Ask Industry Anything. Due to popular demand, we’re running this event again in November 2017!
Academic and research organisations want their researchers to have more exposure to the needs and expectations of industry and to showcase the strengths of their organisation to industry.
Industry want greater access emerging talent, the capabilities within research organisations and to connect with researchers who understand the needs of partners. This event addressed these needs by facilitating open dialogue between the 14 industry and 100 academic and research participants.
Breaking down the barriers, participants from research and academia had the chance to ask industry professionals all the questions that they might think are awkward, naive, controversial or challenging about all aspects of working and engaging with industry partners. The creative logistics of this event involved the rotation of the high calibre industry participants around the academic tables to allow the researchers full access to a diverse representation of industry professionals and establish a greater understanding of approaches to building industry relationships.
Date: 28th November 2017
Time: Registration: 3.45pm for 4.00pm – 6.30pm including networking
Venue: Swanston Hall, Melbourne Town Hall, 90-120 Swanston Street, Melbourne VIC 3000
Dr Vern Bowles, CSO, Hatchtech Pty Ltd
Dr Megan Baldwin, CEO & Managing Director, Opthea Limited
Paul Brennan, CEO, PolyNovo Limited
Mrs Lusia Guthrie, Chairman Clever Culture Systems AG, Experienced CEO and Industry Expert, and Deputy Chair of BioMelbourne Network
Dr Matt Harris, CEO, Clarity Pharmaceuticals
Dr Sacha Dopheide,CEO at Planet Innovation’s Lumos Diagnostics
Dr Lorna Meldrum, VP Commercial Operations Asia/Pacific, Seqirus and Director of BioMelbourne Network
Dr Catherine Osborne, General Manager, Crux Biolab
Dr Sara Prickett, CEO, Aravax
Dr Elaine Saunders, Managing Director, Blamey Saunders Hears
Dr Mark Sullivan, CEO, Medicines Development for Global Health
Dr Rebecca Tunstall, Head of Study Management, GSK Australia
Dr Adam Wardell, Head of Strategy, Innovation & Business Development, Novartis Pharmaceuticals Australia
Ms Karin Innes – Senior Associate, FB Rice
The event will involve a panel discussion (30 minutes) with 3 industry representatives featuring the top 5 – “Ask Industry Anything” questions as voted on by participants. This will be followed by small group sessions with industry representatives speaking for 10 minutes at a table with 8-10 participants (10-12 tables). There will be 4 x 10 minute rotations, such that each table will hear 4 different industry perspectives. This will be followed by an hour networking session that will allow broader engagement and follow-up with the wider audience and a chance to continue the conversation with industry representatives.